Advertisement

Dietary Induction of Phase II Enzymes: A Promising Strategy for Protection Against DNA-Reactive Intermediates in Man?

  • Hans Steinkellner
  • Sylvie Rabot
  • Fekadu Kassie
  • Siegfried Knasmüller
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 500)

Abstract

Over the last decades, strong efforts have been made to identify chemoprotective agents in in vitro models with mammalian cells and in laboratory rodents and numerous molecular studies have been carried out to elucidate the mechanisms of prevention of DNA-damage and tumour formation by dietary constituents. Among the most important protective mechanisms identified are inhibition of activating-and induction of deactivating enzymes. Since humans differ substantially in their drug metabolism from laboratory rodents, it is unclear if animal data on chemoprotective agents can be extrapolated to man. The present article gives a brief overview on the impact of dietary factors on the activity and induction of important phase II enzymes in humans.

Keywords

Epoxide Hydrolase Laboratory Rodent Vegetable Diet Dietary Constituent Garden Cress 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bell, D. A., Thompson, C. L., Taylor J., Miller, C. R, Perera, Hsieh, F. L. L., and Lucier, G. W., 1992,Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: application toglutathione transferase µ, Env Health Perspect. 98: 113.Google Scholar
  2. Bock, K. W., Wiltfang, J., Blume, R, Ullrich, D., and Bircher, J., 1987, Paracetamol as a test drug todetermine glucuronide formation in man. Effects of inducers and of smoking, Eur J Clin Pharmacol. 31: 677.PubMedCrossRefGoogle Scholar
  3. Bock, K. W., 1991, Roles of UDP-glucuronosyltransferases in chemical carcinogenesis, Crit Rev Biochem Molec Biol. 26 (2): 129.CrossRefGoogle Scholar
  4. Doostdar, H., Duthie S. J., Gray, A. G., Burke M. D., 1988, The influence of culture medium composition on drug metabolizing enzyme activities of the human liver-derived Hep-G2 hepatoma cell line, FEBS Lett. 241:15.PubMedCrossRefGoogle Scholar
  5. Gerhäuser, C., You, M., Liu, Jinfang, Moriarty, R. M., Hawthorne, M., Mehta, R. G., Moon, R. C., and Pezzuto J. M., 1997, Cancer chemopreventive potential of sulforamate, an novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes, Cancer Res. 57:272.PubMedGoogle Scholar
  6. Habig, W. H., Pabst, M. J., and Jakoby, W. B., 1974, Glutathione S-transferases. The first enzymatic step in mercapturic acid formation, J Biol Chem. 249: 7130.PubMedGoogle Scholar
  7. Hayes, J. D., and Pulford, D. J., 1995, The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance, Crit Rev in Biochem. and Molec Biol. 30 (6): 445.CrossRefGoogle Scholar
  8. Helzlsouer, K.J., Selmin, O., Huang, H-Y., Strickland, P. T., Hoffman, S., Alberg, A.J., Watson, G.W., Comstock, P., and Bell, D., 1998 Association between glutathione -S-transferase, Ml, Pl, and Tl genetic polymorphisms and development of breast cancer, J Natl Cancer Inst, 90, 7: 512.PubMedCrossRefGoogle Scholar
  9. Kensler, T. W., 1997, Chemoprevention of carcinogen detoxication enzymes, Env Health Perspect. 105, Suppl 4: 965.CrossRefGoogle Scholar
  10. Seidegard, J, and Ekström, G, 1997, The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics, Environ Health Persp. 105, Suppl 4: 791.CrossRefGoogle Scholar
  11. Sato, K., Kitahare, A., Yin, Z., Waragi, F., Nishimura, K., Hatayama, I., Ebina, T., Yamazaki, T., Tsuda, H., and Ito, N., 1984, Induction by butylated hydroxianisole of specific molecular forms of glutathione S-transferase and UDP-glucuronosyl-transférase and inhibition of development of gamma-glutamyl transpeptidase-positive foci in rat liver, Carcinogenesis, 5:473.PubMedCrossRefGoogle Scholar
  12. Sreerama, L., Hedge, M. W., and Sladek, N. E., 1995 Identification of a class 3 aldehyde dehydrogenase in human saliva and increased levels of this enzyme, glutathione S-transferases, and DT-diaphorase in the saliva of subjects who continually ingest large quantities of coffee or broccoli, Clin Cancer Res. 1: 1153.PubMedGoogle Scholar
  13. Steinkellner, H., Hietsch, G., Sreerama, L., Haidinger, G., Gsur, A., Kundi, M. and Knasmüller, S., 2000, Induction of glutathione S-transferases in humans by vegetable diets. in: Food and Cancer Prevention IV: Chemical and Biological Aspects. K.W. Waldron, I.T. Johnson and G. R. Fenwick. ed., The Royal Society of Chemistry, Cambridge.Google Scholar
  14. Taningher, M., Malacarne, D., Izzotti, A., Ugolini, D., and Parodi, S., 1999 Drug metabolism polymorphisms as modulators of cancer susceptibility, Mutat Res. 436: 227.PubMedCrossRefGoogle Scholar
  15. Wattenberg, L. W., 1983 Inhibition of neoplasia by minor dietary constituents, Cancer Res. 43: 2448.Google Scholar
  16. Yamasaki, E., and Ames, B. N., 1977, Concentration of mutagens from urine by adsorption with the non-polar resin XAD-2: cigarette smokers have mutagenic urine, Proc Natl Acad Sc.. 74: 3555.CrossRefGoogle Scholar
  17. Zhang, Y., and Talalay, P., 1994, Anticarcinogenic activities of organic isothiocyanates: Chemistry and mechanisms, Cancer Res. 54: 1976.Google Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Hans Steinkellner
    • 1
  • Sylvie Rabot
    • 2
  • Fekadu Kassie
    • 1
  • Siegfried Knasmüller
    • 1
  1. 1.Institute of Cancer ResearchUniversity of ViennaAustria
  2. 2.Institute de la Recherché AgronomiqueJouy-en-JosasFrance

Personalised recommendations